A Study for Evaluating Safety & Efficacy of Topical Roflumilast 0.3% Foam in Hidradenitis Suppurativa
Abroad (travel likely)RecruitingPHASE2
Conditions
Hidradenitis Suppurativa
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Lakeview Hospital, Covington, Louisiana, United States
Contact: Study coordinator (Carole Bitar, MD)Contact: Principal Investigator (Carole Bitar, MD)Lakeside Hospital, New Orleans, Louisiana, United States
Contact: Principal Investigator (Carole Bitar, MD)LCMC Multi-speciality Clinic, New Orleans, Louisiana, United States
Contact: Principal Investigator (Carole Bitar, MD)University Medical Center, New Orleans, Louisiana, United States
Contact: Principal Investigator (Carole Bitar, MD)
Study leads
Carole Bitar, MD
Principal Investigator
Tulane University